Cyclophosphamide attenuates the degenerative changes induced by CSF from patients with amyotrophic lateral sclerosis in the neonatal rat spinal cord

Journal of the Neurological Sciences

Volumn 185, Issue 2, 2001, Pages 109-118

  Shahani, Neelam ^b   Gourie Devi, M ^a   Nalini, A ^a   Raju, T R ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH AND NEUROSCIENCES   (India)

^b NONE

Author keywords

Amyotrophic lateral sclerosis; Astrocytes; Cyclophosphamide; Motor neurons; Neonatal rats

Indexed keywords

CYCLOPHOSPHAMIDE; GLIAL FIBRILLARY ACIDIC PROTEIN; LACTATE DEHYDROGENASE;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASTROCYTE; ASTROCYTOSIS; CEREBROSPINAL FLUID; CONTROLLED STUDY; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; NEUROFILAMENT; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT; SPINAL CORD ATROPHY; WESTERN BLOTTING;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMALS; ANIMALS, NEWBORN; ANTERIOR HORN CELLS; ASTROCYTES; CEREBROSPINAL FLUID PROTEINS; CYCLOPHOSPHAMIDE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; GLIAL FIBRILLARY ACIDIC PROTEIN; GLIOSIS; IMMUNOHISTOCHEMISTRY; IMMUNOSUPPRESSIVE AGENTS; L-LACTATE DEHYDROGENASE; NERVE DEGENERATION; NEUROFILAMENT PROTEINS; NEUROPROTECTIVE AGENTS; PHOSPHORYLATION; RATS; RATS, WISTAR;

EID: 0035310418     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-510X(01)00479-8     Document Type: Article

References (73)

1. Ten central themes in a decade of ALS research
2. Therapeutic advances in amyotrophic lateral sclerosis
3. Amyotrophic lateral sclerosis: recent advances in pathogenesis and therapeutic trails
4. A controlled trial of riluzole in amyotrophic lateral sclerosis
5. Dose-ranging study of riluzole in amyotrophic lateral sclerosis
6. Immunoglobulins from animal models of motor neuron disease and from human amyotrophic lateral sclerosis patients passively transfer physiological abnormalities to the neuromuscular junction
7. IgG from amyotrophic lateral sclerosis patients increases current through P-type calcium channels in mammalian cerebellar purkinje cells and in isolated channel protein in lipid bilayer
8. 2+ currents in a motor neuron cell line
9. Long-term neuromuscular dysfunction produced by passive transfer of amyotrophic lateral sclerosis immunoglobulins
10. Immunoglobulins from amyotrophic lateral sclerosis patients enhance spontaneous transmitter release from motor-nerve terminals
11. A double-blind study of the effectiveness of cyclosporine in amyotrophic lateral sclerosis
12. Failure of immunosuppression with a ten to 14 day course of high-dose intravenous cyclophosphamide to alter the progression of amyotrophic lateral sclerosis
13. Trial of immunosuppression in amyotrophic lateral sclerosis using total lymphoid irradiation
14. Plasmapheresis in amyotrophic lateral scleorsis
15. Differential effects of prednisone and cyclophosphamide on autoantibodies in human neuromuscular disorders
16. Treatment of ALS with high dose pulse cyclophosphamide
17. Immunosuppressive treatment of motor neuron syndromes
18. Cyclophosphamide alters the clinical and pathological expression of experimental autoimmune gray matter disease
19. Temporary amelioration of symptoms with intravenous cyclophosphamide in amyotrophic lateral sclerosis
20. Cell culture evidence for neuronal degeneration in amyotrophic lateral sclerosis being linked to glutamate AMPA/Kainate receptors
21. Neuron specific invitro cytotoxicity of sera from patients with amyotrophic lateral sclerosis
22. Amyotrophic lateral sclerosis: effect of serum on anterior horn cells in tissue culture
23. Amyotrophic lateral sclerosis sera apply to cultured human spinal cord neurons
24. Amyotrophic lateral sclerosis sera are not cytotoxic to neuroblastoma cells and tissue culture
25. The effect of serum from ALS patients on organotypic nerve and muscle tissue cultures
26. Effects of amyotrophic lateral sclerosis sera on cultured cholinergic neurons
27. ALS serum has no effect on three enzymatic activities in cultured human spinal cords
28. Neurofilament phosphorylation is enhanced in cultured chick spinal cord neurons exposed to cerebrospinal fluid from amyotrophic lateral sclerosis patients
29. Neurofilament phosphorylation is increased in ventral horn neurons of neonatal rat spinal cord exposed to cerebrospinal fluid from patients with amyotrophic lateral sclerosis
30. Reactive astrogliosis in neonatal rat spinal cord after exposure to cerebrospinal fluid from patients with amyotrophic lateral sclerosis
31. El Escorial World Federation of Neurology Criteria for the diagnosis of amyotrophic lateral sclerosis
32. Cleavage of structural proteins during the assembly of the head of bacteriophage T4
33. A rapid and sensitive method for the quantification of microgram quantities of protein utilising the principle of protein dye binding
34. Regulation of the immune response-what can be learnt from immunosuppressants?
35. Effect of cyclophosphamide on immunological control mechanisms
36. Cyclophosphamide inhibition of experimental allergic encephalomyelitis and cellular transfer of the disease in Lewis rats
37. Oxidative metabolism of cyclophosphamide: identification of the hepatic monooxygenase catalysts of drug activation
38. A biologically active metabolite of cyclophosphamide
39. Importance of pharmacokinetic studies on cyclophosphamide (NSC-26271) in understanding its cytotoxic effect
40. Rat brain cytochrome P450: catalytic and immunochemical properties and inducibility of multiple forms
41. Xenobiotic metabolism by brain monooxygenase and other cerebral enzymes.
42. Xenobiotic metabolism in human brain: presence of cytochrome P450 and associated monooxygenase activities
43. Regional distribution of cytochrome P450 in the rat brian: spectral quantitation and contribution of P450 b,e and P450 c,d
44. Cytochrome P450 and associated monooxygenase activities in the rat and human spinal cord: induction, immunological characterization and immunocytochemical localization
45. Identification of endogenously phosphorylated KSP sites in the high molecular weight rat neurofilament protein
46. Multiple phosphorylation sites in mammalian neurofilament polypeptides
47. The distribution of phosphorylation sites among identified proteolytic fragments of mammalian neurofilaments
48. Identification of major multiphosphorylation site in mammalian neurofilaments
49. Neurofilament phosphorylation
50. Neurofilaments and motor neuron disease
51. Progressive neuropathy in transgenic mice expressing the human neurofilament heavy gene: a mouse model of amyotrophic lateral sclerosis
52. Increased expression of neurofilament NF-L produces morphological alterations that resembles pathology of human motor neuron disease
53. Differential cellular phosphorylation of neurofilament heavy side-arms by glycogen synthase kinase-3 and cyclin-dependent kinase 5
54. Brain proline-directed kinase is a neurofilament kinase which displays high sequence homology to p34 cdc2
55. Cdc2-like kinase from rat spinal cord specifically phosphorylates KSPXK motifs in neurofilament protein: isolation and characterization
56. Phosphorylation of high molecular weight neurofilament protein (NF-H) by Cdk5 and p35
57. Cortical and brain stem type Lewy bodies are immunoreactive for cyclin dependent kinase 5
58. Alteration in cyclin-dependent protein kinase 5 (CDK5) protein levels activity and immunocytochemistry in canine motor neuron disease
59. Cyclin dependent kinase-5 in Lewy body like inclusions in anterior horn cells of a patient with sporadic amyotrophic lateral sclerosis
60. Aberrant stress induced phosphorylation of perikaryal neurofilaments
61. Study of proline directed protein kinases involved in phosphorylation of the heavy neurofilament subunit
62. Two novel kinases phosphorylate tau and the KSP site of heavy neurofilament subunits in high stoichiometric ratios
63. Mitogen-activated protein kinases (Erk1,2) phosphorylate lys-ser-pro (KSP) repeats in neurofilament proteins NF-H and NF-M
64. Cytotoxicity DNA cross linking, and single strand breaks induced by activated cyclophosphamide and acrolein in human leukemia cells
65. Ultrastructural evidence for altered calcium in motor nerve terminals in amyotrophic lateral sclerosis
66. Massive mitochondrial degeneration in motor neurons triggers the onset amyotrophic lateral sclerosis in mice expressing a mutant SOD1
67. Immunosuppressant FK 506 promotes neurite outgrowth in cultures of PC 12 cells and sensory ganglia
68. Neurotrophic actions of nonimmunosuppressive analogues of immunosuppressive drugs drugs FK 506, rapamycin and cyclosporin A
69. The immunosuppressant FK 506 increases functional recovery and nerve regeneration following peripheral nerve injury
70. The immunosuppressant FK 506 increases the rate of axonal regeneration in rat sciatic nerve